Marriyam Jawad, MD
Internal Medicine · Kingwood, TXNPI 1649894213
Payments from drug & device makers
Across 45 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$159
- Novo Nordisk$130
- AstraZeneca$78
- Stryker$72
- Inspire Medical Systems, Inc.$69
- Amgen$62
- plus $510 from 14 others
What the payments were for
- Food & beverage$1,080100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 3 | $159 |
| Novo Nordisk | 8 | $130 |
| AstraZeneca(2 entities) | 4 | $78 |
| Stryker | 1 | $72 |
| Inspire Medical Systems, Inc. | 2 | $69 |
| Amgen | 2 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $61 |
| Lilly USA, LLC | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $53 |
| Astellas Pharma US Inc | 2 | $49 |
| Renalytix AI, Inc. | 2 | $44 |
| GSK | 2 | $37 |
| Globus Medical | 1 | $35 |
| Boehringer Ingelheim | 2 | $34 |
| Bayer | 2 | $34 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Vapotherm Inc | 1 | $24 |
| Abiomed | 1 | $23 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Edwards Lifesciences | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$121
How this compares
$1,080 in reported general payments places this provider in the 70th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 42 | $675 |
| Levothyroxine Sodium | 35 | $339 |
| Losartan Potassium | 25 | $319 |
| Amlodipine Besylate | 25 | $302 |
| Lisinopril | 29 | $285 |
| Omeprazole | 23 | $272 |
| Memantine Hcl | 12 | $265 |
| Pantoprazole Sodium | 19 | $242 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $238 |
| Metoprolol Succinate | 17 | $236 |
| Gabapentin | 13 | $229 |
| Quetiapine Fumarate | 12 | $227 |
| Tamsulosin Hcl | 11 | $215 |
| Fluticasone Propionate | 19 | $171 |
| Mupirocin | 17 | $138 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Kingwood
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.